Safety, Acceptance and Metabolic Effects in Infants Receiving a Novel Low Glycaemic Index follow-on Formula

NCT ID: NCT01627015

Last Updated: 2015-03-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the safety, acceptance and metabolic effects in infants receiving a novel low glycaemic index follow-on formula will be investigated.

After 4 week intervention period, metabolic response after feeding is significantly different between a follow-on formula containing low glycaemic carbohydrate and a conventional follow-on formula containing higher glycaemic carbohydrates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infant Nutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Modified infant follow-on formula

Infants are fed a modified infant follow-on formula (modified carbohydrate composition) for 4 weeks, according to protocol

Group Type EXPERIMENTAL

Modified infant follow-on formula

Intervention Type OTHER

The modified infant follow-on formula has a different carbohydrate pattern than the standard formula

Standard infant follow-on formula

Infants are fed a commercial follow-on formula for 4 weeks, according to protocol

Group Type ACTIVE_COMPARATOR

Standard infant follow-on formula

Intervention Type OTHER

Infants are fed a commercial follow-on formula

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Modified infant follow-on formula

The modified infant follow-on formula has a different carbohydrate pattern than the standard formula

Intervention Type OTHER

Standard infant follow-on formula

Infants are fed a commercial follow-on formula

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* generally healthy infants born
* weight between 10th and 90th percentile for age, according to the EURO Growth guidelines
* age between 5 - 7th month of life at study entry
* fully formula fed for at least 4 weeks before intervention start
* parents/caregivers understand the German language and are able to fill out questionnaires
* parents/caregivers agree to study participation and sign the informed consent form

Exclusion Criteria

* acute or chronic illness of infant or mother
* drug and/or alcohol abuses of mother
* chronic medication
* participation of the infant in another intervention study
* gestational diabetes of the mother
Minimum Eligible Age

4 Months

Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beneo GmbH

INDUSTRY

Sponsor Role collaborator

Ludwig-Maximilians - University of Munich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Koletzko - Office

Prof. Berthold Koletzko

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Berthold Koletzko, Prof.

Role: STUDY_DIRECTOR

Germany, Hauner Childrens Hospital, Ludwig-Maximilians - University of Munich

Berthold Koletzko, Prof.

Role: PRINCIPAL_INVESTIGATOR

Germany, Hauner Childrens Hospital, Ludwig-Maximilians - University of Munich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Germany, Hauner Childrens Hospital, Ludwig-Maximilians - University of Munich

Munich, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Fleddermann M, Rauh-Pfeiffer A, Demmelmair H, Holdt L, Teupser D, Koletzko B. Effects of a Follow-On Formula Containing Isomaltulose (Palatinose) on Metabolic Response, Acceptance, Tolerance and Safety in Infants: A Randomized-Controlled Trial. PLoS One. 2016 Mar 17;11(3):e0151614. doi: 10.1371/journal.pone.0151614. eCollection 2016.

Reference Type DERIVED
PMID: 26987056 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

114-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Preterm Infant Growth
NCT01162798 COMPLETED NA